Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

HCT-116

  • Open Access
    Comparison of Cell-death Kinetics of Recombinant Methioninase (rMETase)-treated Cancer and Normal Cells: Only Cancer Cells Undergo Methionine-depletion Catastrophe at Low rMETase Concentrations
    BYUNG MO KANG, QINGHONG HAN, KOHEI MIZUTA, SEI MORINAGA, MICHAEL BOUVET and ROBERT M. HOFFMAN
    Anticancer Research January 2025, 45 (1) 105-111; DOI: https://doi.org/10.21873/anticanres.17397
  • Open Access
    Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells
    DANIEL ARDJMAND, YUTARO KUBOTA, MOTOKAZU SATO, QINGHONG HAN, KOHEI MIZUTA, SEI MORINAGA and ROBERT M. HOFFMAN
    Anticancer Research March 2024, 44 (3) 929-933; DOI: https://doi.org/10.21873/anticanres.16887
  • Open Access
    Recombinant Oral Methioninase (o-rMETase) Combined With Oxaliplatinum Plus 5-Fluorouracil Improves Survival of Mice With Massive Colon-Cancer Peritoneal Carcinomatosis
    MIN JEONG KIM, QINGHONG HAN, MICHAEL BOUVET, ROBERT M. HOFFMAN and JUN HO PARK
    Anticancer Research January 2023, 43 (1) 19-24; DOI: https://doi.org/10.21873/anticanres.16129
  • You have access
    Unravelling the Antiproliferative Activity of 1,2,5-oxadiazole Derivatives
    DANIEL EHRSAM, FABIOLA PORTA, MATTEO MORI, HENRIETTE E. MEYER ZU SCHWABEDISSEN, LISA DALLA VIA, AÌDA NELLY GARCIA-ARGAEZ, LIVIA BASILE, FIORELLA MENEGHETTI, STEFANIA VILLA and ARIANNA GELAIN
    Anticancer Research July 2019, 39 (7) 3453-3461; DOI: https://doi.org/10.21873/anticanres.13491
  • You have access
    Exploring the Biological Activity of a Library of 1,2,5-Oxadiazole Derivatives Endowed With Antiproliferative Activity
    ARIANNA GELAIN, MATTEO MORI, FIORELLA MENEGHETTI, FEDERICA PORTA, LIVIA BASILE, GAETANO MARVERTI, AKIRA ASAI, MARIAFRANCESCA HYERACI, AÍDA NELLY GARCÍA-ARGÁEZ, LISA DALLA VIA, SALVATORE GUCCIONE and STEFANIA VILLA
    Anticancer Research January 2019, 39 (1) 135-144; DOI: https://doi.org/10.21873/anticanres.13089
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire